Earning_Press_Release_HIFY26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Patel Chem Specialities reported a 22% year-on-year rise in revenue to ₹61.16 crore for H1 FY26 (vs ₹50.14 crore in H1 FY25). EBITDA grew 10% to ₹8.39 crore, while profit after tax (PAT) jumped 17% to ₹6.13 crore. Despite the strong top-line growth, EBITDA margin contracted from about 15.3% to 13.7%, indicating rising input or operating costs. The company highlighted healthy demand for its cellulose- and starch-based excipients, 100% repeat orders, and exports to 15+ countries. Management noted capacity expansion plans, including a new 6,012 MTPA Indrad facility and a Vatva unit expected to commence production by December 2025.
Strong revenue growth and capacity expansion plans signal positive long-term momentum for shareholders, but the drop in EBITDA margin is a watch point that could pressure profitability if costs continue to rise.